首页 › 基金 › Palo Alto Investors LP › IOVA
Palo Alto Investors LP 对 IOVA 的持仓历史
IOVANCE BIOTHERAPEUTICS INC · 医疗保健
Palo Alto Investors LP 在 Q3 2026 的 13F 申报中披露持有 IOVA(IOVANCE BIOTHERAPEUTICS INC)3,471,456 股,市值约 US$51.4M,约占其申报组合的 7.65%,在其申报持仓中市值排名第 2 位。 Palo Alto Investors LP 最近 12 个申报季度中有 12 个季度披露了 IOVA 持仓,最早可追溯至 Q4 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Palo Alto Investors LP 对 IOVA 的持仓演变
Palo Alto Investors LP 于 Q4 2023 首次披露 IOVA 持仓:2,106,792 股(约 US$17.1M)。 该持仓在 Q3 2026 达到峰值 3,471,456 股,市值约 US$51.4M。 在 12 次申报中,Palo Alto Investors LP 4 次增持、4 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 3,471,456 股、市值约 US$51.4M,环比减持 -1,824,753 股。。 持仓曾出现大幅变动:Q3 2024 增持约 44% (随后一个季度股价下跌 21%)、Q3 2025 增持约 122% (随后一个季度股价上涨 26%)、Q3 2026 减持约 34% (随后一个季度股价下跌 49%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2023 | 2.11M | $17.13M | 新进 |
| Q1 2024 | 2.11M | $31.31M | 持有 |
| Q2 2024 | 2.12M | $16.97M | 持有 |
| Q3 2024 | 3.04M | $28.56M | 增持 |
| Q4 2024 | 3.04M | $22.51M | 持有 |
| Q1 2025 | 3.21M | $10.69M | 增持 |
| Q2 2025 | 3.43M | $5.90M | 增持 |
| Q3 2025 | 7.62M | $16.53M | 增持 |
| Q4 2025 | 7.12M | $19.43M | 减持 |
| Q1 2026 | 6.35M | $22.29M | 减持 |
| Q2 2026 | 5.30M | $22.03M | 减持 |
| Q3 2026 | 3.47M | $51.45M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IOVA 与 13F 数据
IOVA(IOVANCE BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 IOVA,申报仓位最大的包括:MHR FUND MANAGEMENT LLC (US$429.3M), MPM BioImpact LLC (US$42.0M), Rhenman & Partners Asset Management AB (US$37.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IOVA 的基金
- MHR FUND MANAGEMENT LLC 28.97M 股 · $429.29M · Q3 2026
- MPM BioImpact LLC 2.84M 股 · $42.03M · Q3 2026
- Rhenman & Partners Asset Management AB 2.50M 股 · $37.09M · Q3 2026
- Orion Investment Co 2.08M 股 · $30.88M · Q3 2026
- 683 Capital Management, LLC 2.04M 股 · $30.24M · Q3 2026
- XCELSIOR ADVISOR PARTNERS LLC 1.84M 股 · $27.29M · Q3 2026
- C WorldWide Group Holding A/S 1.26M 股 · $18.67M · Q3 2026
- Knott David M Jr 1.17M 股 · $17.27M · Q3 2026
- Mirador Capital Partners LP 1.10M 股 · $16.24M · Q3 2026
更多关于 Palo Alto Investors LP
常见问题
How long has Palo Alto Investors LP held IOVA?
Palo Alto Investors LP has disclosed IOVA holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Palo Alto Investors LP's current position in IOVA?
As of Q3 2026, Palo Alto Investors LP holds 3.47M shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), valued at $51.45M, representing 7.65% of its reported portfolio and ranking #2.
Has Palo Alto Investors LP been buying or selling IOVA?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in IOVA. The position peaked in Q3 2026 at 3.47M shares.
Which other funds hold IOVA?
Other major institutional holders of IOVA include MHR FUND MANAGEMENT LLC, MPM BioImpact LLC, Rhenman & Partners Asset Management AB, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.